Fusidic acid cream for impetigo: Authors’ reply

S. Koning; L. W.A. Van Suijlekom-Smit; J. L. Nouwen; C. M. Verduin; R. M.D. Bernsen; A. P. Oranje; S. Thomas; J. C. Van Der Wouden

doi:10.1136/bmj.324.7350.1394/a

Fusidic acid cream for impetigo: Authors’ reply

S. Koning, L. W.A. Van Suijlekom-Smit, J. L. Nouwen, C. M. Verduin, R. M.D. Bernsen, A. P. Oranje, S. Thomas, J. C. Van Der Wouden

Research output: Contribution to journal › Comment/Letter to the editor › Professional › peer-review

32 Citations (Scopus)

Abstract

Guidelines for treating impetigo may vary between countries or regions. The wish to reserve certain antibiotics for specific vital conditions, and local resistance rates, may vary and lead to different recommendations. The letters commenting on our article focus on the question of whether the use of fusidic acid cream should be promoted in the United Kingdom in light of the higher reported staphylococcal resistance rates to fusidic acid in the United Kingdom and the risk of rising resistance rates because of its use.
The main purpose of our study was to assess the effectiveness of fusidic acid cream in impetigo compared with disinfection with povidone iodine alone. The large treatment effect we found may partly be explained by the low resistance rate to fusidic acid, which was an unexpected co-finding. We used Vitek II equipment to test the susceptibility of isolates, using the guidelines of the national committee for clinical laboratory standards to categorise strains as resistant, intermediately sensitive, or sensitive, as described in the website version of our article. [...]

Original language	English
Pages (from-to)	1396-1397
Number of pages	2
Journal	BMJ
Volume	324
Issue number	7350
DOIs	https://doi.org/10.1136/bmj.324.7350.1394/a
Publication status	Published - 8 Jun 2002

Access to Document

10.1136/bmj.324.7350.1394/a

Cite this

@article{00fe61fb44e047ecb85f096d6d33f9d5,

title = "Fusidic acid cream for impetigo: Authors{\textquoteright} reply",

abstract = "Guidelines for treating impetigo may vary between countries or regions. The wish to reserve certain antibiotics for specific vital conditions, and local resistance rates, may vary and lead to different recommendations. The letters commenting on our article focus on the question of whether the use of fusidic acid cream should be promoted in the United Kingdom in light of the higher reported staphylococcal resistance rates to fusidic acid in the United Kingdom and the risk of rising resistance rates because of its use. The main purpose of our study was to assess the effectiveness of fusidic acid cream in impetigo compared with disinfection with povidone iodine alone. The large treatment effect we found may partly be explained by the low resistance rate to fusidic acid, which was an unexpected co-finding. We used Vitek II equipment to test the susceptibility of isolates, using the guidelines of the national committee for clinical laboratory standards to categorise strains as resistant, intermediately sensitive, or sensitive, as described in the website version of our article. [...]",

author = "S. Koning and {Van Suijlekom-Smit}, {L. W.A.} and Nouwen, {J. L.} and Verduin, {C. M.} and Bernsen, {R. M.D.} and Oranje, {A. P.} and S. Thomas and {Van Der Wouden}, {J. C.}",

year = "2002",

month = jun,

day = "8",

doi = "10.1136/bmj.324.7350.1394/a",

language = "English",

volume = "324",

pages = "1396--1397",

journal = "BMJ",

issn = "0959-8138",

publisher = "BMJ Publishing Group",

number = "7350",

}

TY - JOUR

T1 - Fusidic acid cream for impetigo: Authors’ reply

AU - Koning, S.

AU - Van Suijlekom-Smit, L. W.A.

AU - Nouwen, J. L.

AU - Verduin, C. M.

AU - Bernsen, R. M.D.

AU - Oranje, A. P.

AU - Thomas, S.

AU - Van Der Wouden, J. C.

PY - 2002/6/8

Y1 - 2002/6/8

N2 - Guidelines for treating impetigo may vary between countries or regions. The wish to reserve certain antibiotics for specific vital conditions, and local resistance rates, may vary and lead to different recommendations. The letters commenting on our article focus on the question of whether the use of fusidic acid cream should be promoted in the United Kingdom in light of the higher reported staphylococcal resistance rates to fusidic acid in the United Kingdom and the risk of rising resistance rates because of its use. The main purpose of our study was to assess the effectiveness of fusidic acid cream in impetigo compared with disinfection with povidone iodine alone. The large treatment effect we found may partly be explained by the low resistance rate to fusidic acid, which was an unexpected co-finding. We used Vitek II equipment to test the susceptibility of isolates, using the guidelines of the national committee for clinical laboratory standards to categorise strains as resistant, intermediately sensitive, or sensitive, as described in the website version of our article. [...]

AB - Guidelines for treating impetigo may vary between countries or regions. The wish to reserve certain antibiotics for specific vital conditions, and local resistance rates, may vary and lead to different recommendations. The letters commenting on our article focus on the question of whether the use of fusidic acid cream should be promoted in the United Kingdom in light of the higher reported staphylococcal resistance rates to fusidic acid in the United Kingdom and the risk of rising resistance rates because of its use. The main purpose of our study was to assess the effectiveness of fusidic acid cream in impetigo compared with disinfection with povidone iodine alone. The large treatment effect we found may partly be explained by the low resistance rate to fusidic acid, which was an unexpected co-finding. We used Vitek II equipment to test the susceptibility of isolates, using the guidelines of the national committee for clinical laboratory standards to categorise strains as resistant, intermediately sensitive, or sensitive, as described in the website version of our article. [...]

UR - http://www.scopus.com/inward/record.url?scp=85007696299&partnerID=8YFLogxK

U2 - 10.1136/bmj.324.7350.1394/a

DO - 10.1136/bmj.324.7350.1394/a

M3 - Comment/Letter to the editor

C2 - 12052817

AN - SCOPUS:85007696299

SN - 0959-8138

VL - 324

SP - 1396

EP - 1397

JO - BMJ

JF - BMJ

IS - 7350

ER -

Fusidic acid cream for impetigo: Authors’ reply

Abstract

Access to Document

Other files and links

Fingerprint

Fusidic acid cream for impetigo (multiple letters)

Cite this